Oruka Therapeutics, Inc. (ORKA) · Insider trading

What Oruka Therapeutics's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.

Bought, 12 months

0 insiders, 0 trades

Sold, 12 months

$336.97M

7 insiders, 11% under a plan

Net, 12 months

−$336.97M

bought less sold

Latest filing

2026-10-15

filings read to 2026-10-19

Bought and sold at the market, by month

Two years. Purchases above the line, sales below, in dollars.

Bought Sold Largest month: $301.94M

Who traded, two years

Insider	Bought	Sold	Trades	Last trade	Holds after
Harwin Peter EvanDirector, 10% owner	–	$300.01M	1	2026-07-01	–
Klein Lawrence OttoDirector, Chief Executive Officer	–	$9.40M	9	2026-10-01	931,882
Dambkowski CarlDirector	–	$8.65M	5	2026-06-12	38,743
Quinlan Paul TGeneral Counsel	–	$6.76M	13	2026-09-21	37,095
Agarwal ArjunSenior Vice President, Finance	–	$5.14M	30	2026-10-12	18,477
Goncalves JoanaChief Medical Officer	–	$5.07M	40	2026-10-15	35,918
Sandler Laura LeeChief Operating Officer	–	$1.94M	19	2026-09-15	235,478
Koh Bong Y10% owner	$1.41M	–	5	2025-02-14	–

Open-market purchases and sales

Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.

Date	Insider	Trade	Shares	Price	Value	Holds after	Filing
2026-10-15	Goncalves JoanaChief Medical Officer	Saleplan	2,853	73.89	$210,806	35,918	Form 4
2026-10-15	Goncalves JoanaChief Medical Officer	Saleplan	1,847	74.69	$137,957	34,071	Form 4
2026-10-15	Goncalves JoanaChief Medical Officer	Saleplan	1,400	75.48	$105,677	32,671	Form 4
2026-10-15	Goncalves JoanaChief Medical Officer	Saleplan	700	76.67	$53,666	31,971	Form 4
2026-10-15	Goncalves JoanaChief Medical Officer	Saleplan	200	77.71	$15,542	31,771	Form 4
2026-10-12	Agarwal ArjunSenior Vice President, Finance	Saleplan	5,741	80.03	$459,453	18,477	Form 4
2026-10-12	Agarwal ArjunSenior Vice President, Finance	Saleplan	2,100	80.76	$169,596	16,377	Form 4
2026-10-12	Agarwal ArjunSenior Vice President, Finance	Saleplan	1,958	81.86	$160,272	14,419	Form 4
2026-10-12	Agarwal ArjunSenior Vice President, Finance	Saleplan	200	82.83	$16,567	14,219	Form 4
2026-10-01	Klein Lawrence OttoDirector, Chief Executive Officer	Saleplan	16,246	83.40	$1.35M	931,882	Form 4
2026-10-01	Klein Lawrence OttoDirector, Chief Executive Officer	Saleplan	8,554	84.03	$718,755	923,328	Form 4
2026-10-01	Klein Lawrence OttoDirector, Chief Executive Officer	Saleplan	200	84.78	$16,956	923,128	Form 4
2026-09-21	Quinlan Paul TGeneral Counsel	Saleplan	2,900	92.37	$267,873	37,095	Form 4
2026-09-21	Quinlan Paul TGeneral Counsel	Saleplan	3,832	93.32	$357,602	33,263	Form 4
2026-09-21	Quinlan Paul TGeneral Counsel	Saleplan	601	94.44	$56,758	32,662	Form 4
2026-09-21	Quinlan Paul TGeneral Counsel	Saleplan	2,667	95.31	$254,192	29,995	Form 4
2026-09-21	Agarwal ArjunSenior Vice President, Finance	Saleplan	533	95.75	$51,035	14,219	Form 4
2026-09-15	Sandler Laura LeeChief Operating Officer	Sale	906	95.71	$86,713	235,478	Form 4
2026-09-15	Quinlan Paul TGeneral Counsel	Sale	1,039	95.71	$99,443	29,995	Form 4
2026-09-15	Klein Lawrence OttoDirector, Chief Executive Officer	Sale	2,452	95.71	$234,681	923,128	Form 4
2026-09-15	Agarwal ArjunSenior Vice President, Finance	Saleplan	560	95.71	$53,598	14,752	Form 4
2026-09-15	Goncalves JoanaChief Medical Officer	Saleplan	2,384	91.10	$217,182	37,334	Form 4
2026-09-15	Goncalves JoanaChief Medical Officer	Saleplan	3,150	92.03	$289,894	34,184	Form 4
2026-09-15	Goncalves JoanaChief Medical Officer	Saleplan	1,366	92.99	$127,024	32,818	Form 4
2026-09-15	Goncalves JoanaChief Medical Officer	Saleplan	100	94.22	$9,422	32,718	Form 4
2026-09-15	Goncalves JoanaChief Medical Officer	Saleplan	947	95.71	$90,637	31,771	Form 4
2026-09-11	Agarwal ArjunSenior Vice President, Finance	Saleplan	3,000	91.11	$273,330	21,771	Form 4
2026-09-11	Agarwal ArjunSenior Vice President, Finance	Saleplan	4,051	92.41	$374,353	17,720	Form 4
2026-09-11	Agarwal ArjunSenior Vice President, Finance	Saleplan	2,208	93.26	$205,918	15,512	Form 4
2026-09-11	Agarwal ArjunSenior Vice President, Finance	Saleplan	200	94.02	$18,804	15,312	Form 4
2026-09-01	Klein Lawrence OttoDirector, Chief Executive Officer	Saleplan	6,604	90.79	$599,577	993,976	Form 4
2026-09-01	Klein Lawrence OttoDirector, Chief Executive Officer	Saleplan	63,596	91.90	$5.84M	930,380	Form 4
2026-09-01	Klein Lawrence OttoDirector, Chief Executive Officer	Saleplan	4,800	92.44	$443,712	925,580	Form 4
2026-09-01	Sandler Laura LeeChief Operating Officer	Saleplan	1,000	91.05	$91,050	240,384	Form 4
2026-09-01	Sandler Laura LeeChief Operating Officer	Saleplan	4,000	92.01	$368,040	236,384	Form 4
2026-08-17	Goncalves JoanaChief Medical Officer	Saleplan	900	109.65	$98,685	38,818	Form 4
2026-08-17	Goncalves JoanaChief Medical Officer	Saleplan	300	110.52	$33,156	38,518	Form 4
2026-08-17	Goncalves JoanaChief Medical Officer	Saleplan	3,320	112.01	$371,873	35,198	Form 4
2026-08-17	Goncalves JoanaChief Medical Officer	Saleplan	2,480	112.56	$279,149	32,718	Form 4
2026-08-14	Quinlan Paul TGeneral Counsel	Saleplan	3,630	106.05	$384,962	79,404	Form 4

82 more

2026-08-14	Quinlan Paul TGeneral Counsel	Saleplan	10,434	107.14	$1.12M	68,970	Form 4
2026-08-14	Quinlan Paul TGeneral Counsel	Saleplan	14,696	107.97	$1.59M	54,274	Form 4
2026-08-14	Quinlan Paul TGeneral Counsel	Saleplan	10,200	109.11	$1.11M	44,074	Form 4
2026-08-14	Quinlan Paul TGeneral Counsel	Saleplan	9,193	110.00	$1.01M	34,881	Form 4
2026-08-14	Quinlan Paul TGeneral Counsel	Saleplan	3,847	111.14	$427,556	31,034	Form 4
2026-08-13	Agarwal ArjunSenior Vice President, Finance	Saleplan	2,100	104.67	$219,807	23,212	Form 4
2026-08-13	Agarwal ArjunSenior Vice President, Finance	Saleplan	2,132	105.57	$225,075	21,080	Form 4
2026-08-13	Agarwal ArjunSenior Vice President, Finance	Saleplan	1,268	106.63	$135,207	19,812	Form 4
2026-08-13	Agarwal ArjunSenior Vice President, Finance	Saleplan	2,142	107.71	$230,715	17,670	Form 4
2026-08-13	Agarwal ArjunSenior Vice President, Finance	Saleplan	2,358	108.46	$255,749	15,312	Form 4
2026-07-15	Goncalves JoanaChief Medical Officer	Saleplan	400	84.37	$33,748	39,318	Form 4
2026-07-15	Goncalves JoanaChief Medical Officer	Saleplan	2,497	85.86	$214,392	36,821	Form 4
2026-07-15	Goncalves JoanaChief Medical Officer	Saleplan	3,803	86.68	$329,644	33,018	Form 4
2026-07-15	Goncalves JoanaChief Medical Officer	Saleplan	300	87.25	$26,175	32,718	Form 4
2026-07-13	Agarwal ArjunSenior Vice President, Finance	Saleplan	300	83.07	$24,921	25,011	Form 4
2026-07-13	Agarwal ArjunSenior Vice President, Finance	Saleplan	3,743	84.26	$315,385	21,268	Form 4
2026-07-13	Agarwal ArjunSenior Vice President, Finance	Saleplan	5,656	84.90	$480,194	15,612	Form 4
2026-07-13	Agarwal ArjunSenior Vice President, Finance	Saleplan	300	85.63	$25,689	15,312	Form 4
2026-07-01	Sandler Laura LeeChief Operating Officer	Saleplan	2,237	93.85	$209,942	239,147	Form 4
2026-07-01	Sandler Laura LeeChief Operating Officer	Saleplan	2,263	94.75	$214,419	236,884	Form 4
2026-07-01	Sandler Laura LeeChief Operating Officer	Saleplan	500	95.47	$47,735	236,384	Form 4
2026-07-01	Harwin Peter EvanDirector, 10% ownerwith Fairmount Healthcare Fund II L.P., Fairmount Funds Management LLC, Kiselak Tomas, Fairmount Healthcare Co-Invest III L.P.	Saleindirect	3,553,410	84.43	$300.01M	1,131,954	Form 4
2026-06-22	Agarwal ArjunSenior Vice President, Finance	Saleplan	888	80.01	$71,049	16,011	Form 4
2026-06-22	Agarwal ArjunSenior Vice President, Finance	Saleplan	699	82.15	$57,423	15,312	Form 4
2026-06-15	Quinlan Paul TGeneral Counsel	Sale	733	69.69	$51,083	31,034	Form 4
2026-06-15	Sandler Laura LeeChief Operating Officer	Sale	600	69.69	$41,814	236,384	Form 4
2026-06-15	Klein Lawrence OttoDirector, Chief Executive Officer	Sale	1,729	69.69	$120,494	925,580	Form 4
2026-06-15	Goncalves JoanaChief Medical Officer	Saleplan	1,636	68.38	$111,870	39,029	Form 4
2026-06-15	Goncalves JoanaChief Medical Officer	Saleplan	5,064	69.42	$351,543	33,965	Form 4
2026-06-15	Goncalves JoanaChief Medical Officer	Saleplan	300	70.62	$21,186	33,665	Form 4
2026-06-15	Goncalves JoanaChief Medical Officer	Saleplan	947	69.69	$65,996	32,718	Form 4
2026-06-15	Agarwal ArjunSenior Vice President, Finance	Saleplan	395	69.69	$27,528	16,899	Form 4
2026-06-12	Agarwal ArjunSenior Vice President, Finance	Saleplan	1,859	68.34	$127,044	24,894	Form 4
2026-06-12	Agarwal ArjunSenior Vice President, Finance	Saleplan	4,340	69.85	$303,149	20,554	Form 4
2026-06-12	Agarwal ArjunSenior Vice President, Finance	Saleplan	3,260	70.34	$229,308	17,294	Form 4
2026-06-12	Dambkowski CarlDirector	Saleplan	12,583	70.11	$882,194	38,743	Form 4
2026-06-11	Dambkowski CarlDirector	Saleplan	22,417	70.13	$1.57M	51,326	Form 4
2026-05-21	Dambkowski CarlDirector	Saleplan	38,318	58.43	$2.24M	140,425	Form 4
2026-05-21	Dambkowski CarlDirector	Saleplan	53,447	59.10	$3.16M	86,978	Form 4
2026-05-21	Dambkowski CarlDirector	Saleplan	13,235	59.97	$793,703	73,743	Form 4
2026-05-18	Agarwal ArjunSenior Vice President, Finance	Saleplan	4,190	58.34	$244,445	22,506	Form 4
2026-05-18	Agarwal ArjunSenior Vice President, Finance	Saleplan	4,600	59.19	$272,274	17,906	Form 4
2026-05-18	Agarwal ArjunSenior Vice President, Finance	Saleplan	800	60.34	$48,272	17,106	Form 4
2026-05-18	Agarwal ArjunSenior Vice President, Finance	Saleplan	700	61.16	$42,812	16,406	Form 4
2026-05-15	Goncalves JoanaChief Medical Officer	Saleplan	4,800	61.56	$295,488	35,577	Form 4
2026-05-15	Goncalves JoanaChief Medical Officer	Saleplan	2,100	62.42	$131,082	33,477	Form 4
2026-05-15	Goncalves JoanaChief Medical Officer	Saleplan	100	63.52	$6,352	33,377	Form 4
2026-05-01	Sandler Laura LeeChief Operating Officer	Saleplan	2,200	62.58	$137,676	239,784	Form 4
2026-05-01	Sandler Laura LeeChief Operating Officer	Saleplan	1,800	64.15	$115,470	237,984	Form 4
2026-05-01	Sandler Laura LeeChief Operating Officer	Saleplan	300	65.10	$19,530	237,684	Form 4
2026-05-01	Sandler Laura LeeChief Operating Officer	Saleplan	400	66.06	$26,424	237,284	Form 4
2026-05-01	Sandler Laura LeeChief Operating Officer	Saleplan	200	67.16	$13,432	237,084	Form 4
2026-05-01	Sandler Laura LeeChief Operating Officer	Saleplan	100	68.48	$6,848	236,984	Form 4
2026-04-15	Goncalves JoanaChief Medical Officer	Saleplan	4,227	65.73	$277,841	36,150	Form 4
2026-04-15	Goncalves JoanaChief Medical Officer	Saleplan	2,273	66.56	$151,291	33,877	Form 4
2026-04-15	Goncalves JoanaChief Medical Officer	Saleplan	500	67.38	$33,690	33,377	Form 4
2026-03-16	Quinlan Paul TGeneral Counsel	Sale	733	41.30	$30,273	31,767	Form 4
2026-03-16	Goncalves JoanaChief Medical Officer	Saleplan	2,921	40.11	$117,161	38,097	Form 4
2026-03-16	Goncalves JoanaChief Medical Officer	Saleplan	2,902	41.20	$119,562	35,195	Form 4
2026-03-16	Goncalves JoanaChief Medical Officer	Saleplan	1,177	41.94	$49,363	34,018	Form 4
2026-03-16	Goncalves JoanaChief Medical Officer	Saleplan	641	41.30	$26,473	33,377	Form 4
2026-03-16	Sandler Laura LeeChief Operating Officer	Sale	600	41.30	$24,780	236,984	Form 4
2026-03-16	Agarwal ArjunSenior Vice President, Finance	Sale	395	41.30	$16,313	18,863	Form 4
2026-03-16	Klein Lawrence OttoDirector, Chief Executive Officer	Sale	1,729	41.30	$71,408	927,309	Form 4
2026-03-02	Sandler Laura LeeChief Operating Officer	Saleplan	2,325	33.28	$77,376	240,259	Form 4
2026-03-02	Sandler Laura LeeChief Operating Officer	Saleplan	2,675	33.81	$90,442	237,584	Form 4
2026-02-17	Goncalves JoanaChief Medical Officer	Saleplan	6,064	32.30	$195,867	34,954	Form 4
2026-02-17	Goncalves JoanaChief Medical Officer	Saleplan	936	32.78	$30,682	34,018	Form 4
2026-01-15	Goncalves JoanaChief Medical Officer	Saleplan	4,381	31.56	$138,264	4,137	Form 4
2026-01-15	Goncalves JoanaChief Medical Officer	Saleplan	2,619	32.24	$84,437	1,518	Form 4
2026-01-02	Sandler Laura LeeChief Operating Officer	Saleplan	8,748	28.17	$246,431	209,336	Form 4
2026-01-02	Sandler Laura LeeChief Operating Officer	Saleplan	3,144	29.08	$91,428	206,192	Form 4
2026-01-02	Sandler Laura LeeChief Operating Officer	Saleplan	1,108	29.75	$32,963	205,084	Form 4
2025-12-19	Goncalves JoanaChief Medical Officer	Saleplan	641	28.53	$18,288	7,877	Form 4
2025-12-19	Goncalves JoanaChief Medical Officer	Saleplan	1,787	29.62	$52,931	6,090	Form 4
2025-12-19	Goncalves JoanaChief Medical Officer	Saleplan	1,492	30.70	$45,804	4,598	Form 4
2025-12-19	Goncalves JoanaChief Medical Officer	Saleplan	3,080	31.58	$97,266	1,518	Form 4
2025-02-14	Koh Bong Y10% ownerwith Shah Nimish P, Venrock Healthcare Capital Partners III, L.P., Vhcp Management III, LLC, Vhcp Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners Eg, L.P., Vhcp Management Eg, LLC	Buyindirect	88,794	11.44	$1.02M	4,148,428	Form 4
2025-02-13	Koh Bong Y10% ownerwith Shah Nimish P, Venrock Healthcare Capital Partners III, L.P., Vhcp Management III, LLC, Vhcp Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners Eg, L.P., Vhcp Management Eg, LLC	Buyindirect	14,950	11.63	$173,868	4,059,634	Form 4
2025-02-12	Koh Bong Y10% ownerwith Shah Nimish P, Venrock Healthcare Capital Partners III, L.P., Vhcp Management III, LLC, Vhcp Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners Eg, L.P., Vhcp Management Eg, LLC	Buyindirect	8,971	11.86	$106,396	4,044,684	Form 4
2025-02-11	Koh Bong Y10% ownerwith Shah Nimish P, Venrock Healthcare Capital Partners III, L.P., Vhcp Management III, LLC, Vhcp Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners Eg, L.P., Vhcp Management Eg, LLC	Buyindirect	9,593	10.95	$105,043	4,035,713	Form 4
2025-02-10	Koh Bong Y10% ownerwith Shah Nimish P, Venrock Healthcare Capital Partners III, L.P., Vhcp Management III, LLC, Vhcp Co-Investment Holdings III, LLC, Venrock Healthcare Capital Partners Eg, L.P., Vhcp Management Eg, LLC	Buyindirect	574	10.90	$6,257	4,026,120	Form 4

Grants, exercises and other transactions

Pay, tax and paperwork rather than a choice to trade at the market price. Two years.

48 × option exercise7 × grant or award1 × conversion1 × other

Show them

Date	Insider	What	Shares	Price	Holds after	Filing
2026-10-15	Goncalves JoanaChief Medical Officer	Option exercise M	+3,500	6.84	35,271	Form 4
2026-10-15	Goncalves JoanaChief Medical Officer	Option exercise M	+3,500	7.80	38,771	Form 4
2026-10-12	Agarwal ArjunSenior Vice President, Finance	Option exercise M	+8,541	12.50	22,760	Form 4
2026-10-12	Agarwal ArjunSenior Vice President, Finance	Option exercise M	+1,458	34.39	24,218	Form 4
2026-10-01	Klein Lawrence OttoDirector, Chief Executive Officer	Option exercise M	+25,000	7.80	948,128	Form 4
2026-09-21	Quinlan Paul TGeneral Counsel	Option exercise M	+10,000	7.80	39,995	Form 4
2026-09-15	Goncalves JoanaChief Medical Officer	Option exercise M	+3,500	6.84	36,218	Form 4
2026-09-15	Goncalves JoanaChief Medical Officer	Option exercise M	+3,500	7.80	39,718	Form 4
2026-09-11	Agarwal ArjunSenior Vice President, Finance	Option exercise M	+8,000	12.50	23,312	Form 4
2026-09-11	Agarwal ArjunSenior Vice President, Finance	Option exercise M	+1,459	34.39	24,771	Form 4
2026-09-01	Klein Lawrence OttoDirector, Chief Executive Officer	Option exercise M	+75,000	7.80	1,000,580	Form 4
2026-09-01	Sandler Laura LeeChief Operating Officer	Option exercise M	+5,000	7.80	241,384	Form 4
2026-08-24	Edwards Larry ToddChief Commercial Officer	Grant or award A	+100,000	–	100,000	Form 4
2026-08-17	Goncalves JoanaChief Medical Officer	Option exercise M	+3,500	6.84	36,218	Form 4
2026-08-17	Goncalves JoanaChief Medical Officer	Option exercise M	+3,500	7.80	39,718	Form 4
2026-08-14	Quinlan Paul TGeneral Counsel	Option exercise M	+10,000	7.80	41,034	Form 4
2026-08-14	Quinlan Paul TGeneral Counsel	Option exercise M	+42,000	12.50	83,034	Form 4
2026-08-13	Agarwal ArjunSenior Vice President, Finance	Option exercise M	+8,542	12.50	23,854	Form 4
2026-08-13	Agarwal ArjunSenior Vice President, Finance	Option exercise M	+1,458	34.39	25,312	Form 4
2026-07-15	Goncalves JoanaChief Medical Officer	Option exercise M	+3,500	6.84	36,218	Form 4
2026-07-15	Goncalves JoanaChief Medical Officer	Option exercise M	+3,500	7.80	39,718	Form 4
2026-07-13	Agarwal ArjunSenior Vice President, Finance	Option exercise M	+8,541	12.50	23,853	Form 4
2026-07-13	Agarwal ArjunSenior Vice President, Finance	Option exercise M	+1,458	34.39	25,311	Form 4
2026-07-01	Sandler Laura LeeChief Operating Officer	Option exercise M	+5,000	7.80	241,384	Form 4
2026-07-01	Harwin Peter EvanDirector, 10% owner	Conversion C	+3,553,410	–	4,685,364	Form 4
2026-06-15	Goncalves JoanaChief Medical Officer	Option exercise M	+3,500	6.84	37,165	Form 4
2026-06-15	Goncalves JoanaChief Medical Officer	Option exercise M	+3,500	7.80	40,665	Form 4
2026-06-12	Agarwal ArjunSenior Vice President, Finance	Option exercise M	+8,000	12.50	25,294	Form 4
2026-06-12	Agarwal ArjunSenior Vice President, Finance	Option exercise M	+1,459	34.39	26,753	Form 4
2026-05-21	Dambkowski CarlDirector	Option exercise M	+38,689	6.84	155,172	Form 4
2026-05-21	Dambkowski CarlDirector	Option exercise M	+11,904	7.80	167,076	Form 4
2026-05-21	Dambkowski CarlDirector	Option exercise M	+11,667	11.77	178,743	Form 4
2026-05-18	Agarwal ArjunSenior Vice President, Finance	Option exercise M	+2,000	12.50	20,863	Form 4
2026-05-18	Agarwal ArjunSenior Vice President, Finance	Option exercise M	+5,833	34.39	26,696	Form 4
2026-05-15	Goncalves JoanaChief Medical Officer	Option exercise M	+3,500	6.84	36,877	Form 4
2026-05-15	Goncalves JoanaChief Medical Officer	Option exercise M	+3,500	7.80	40,377	Form 4
2026-05-01	Sandler Laura LeeChief Operating Officer	Option exercise M	+5,000	7.80	241,984	Form 4
2026-04-15	Goncalves JoanaChief Medical Officer	Option exercise M	+3,500	6.84	36,877	Form 4
2026-04-15	Goncalves JoanaChief Medical Officer	Option exercise M	+3,500	7.80	40,377	Form 4
2026-03-16	Goncalves JoanaChief Medical Officer	Option exercise M	+3,500	6.84	37,518	Form 4
2026-03-16	Goncalves JoanaChief Medical Officer	Option exercise M	+3,500	7.80	41,018	Form 4
2026-03-02	Sandler Laura LeeChief Operating Officer	Option exercise M	+5,000	7.80	242,584	Form 4
2026-02-17	Goncalves JoanaChief Medical Officer	Option exercise M	+3,500	6.84	37,518	Form 4
2026-02-17	Goncalves JoanaChief Medical Officer	Option exercise M	+3,500	7.80	41,018	Form 4
2026-01-23	Dambkowski CarlDirector	Other J	+116,483	–	116,483	Form 4
2026-01-23	Quinlan Paul TGeneral Counsel	Grant or award A	+32,500	–	32,500	Form 4
2026-01-23	Klein Lawrence OttoDirector, Chief Executive Officer	Grant or award A	+76,700	–	929,038	Form 4
2026-01-23	Agarwal ArjunSVP, Finance	Grant or award A	+17,500	–	19,258	Form 4
2026-01-23	Sandler Laura LeeChief Operating Officer	Grant or award A	+32,500	–	237,584	Form 4
2026-01-23	Goncalves JoanaChief Medical Officer	Grant or award A	+32,500	–	34,018	Form 4
2026-01-15	Goncalves JoanaChief Medical Officer	Option exercise M	+3,500	6.84	5,018	Form 4
2026-01-15	Goncalves JoanaChief Medical Officer	Option exercise M	+3,500	7.80	8,518	Form 4
2026-01-02	Sandler Laura LeeChief Operating Officer	Option exercise M	+5,000	7.80	218,084	Form 4
2025-12-19	Goncalves JoanaChief Medical Officer	Option exercise M	+3,500	6.84	5,018	Form 4
2025-12-19	Goncalves JoanaChief Medical Officer	Option exercise M	+3,500	7.80	8,518	Form 4
2025-09-17	Harwin Peter EvanDirector, 10% owner	Grant or award A	+333,340	15.00	1,131,954	Form 4
2024-11-19	Harwin Peter EvanDirector, 10% owner	Option exercise M	+160,000	–	798,614	Form 4

How to read it

Buy, sale: Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
Plan: A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
Holds after: The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
Value: Shares times the price the form reports, which is often an average over several fills on the day.

Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.

Oruka Therapeutics's scores and multiples ›